GleamWall
中文EN

IRTC iRhythm Holdings, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1388658 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.6%
TTM net income YoY25.0%
TTM EPS YoY27.3%
Revenue 3-yr CAGR21.8%
Net income 3-yr CAGR—

Margins

Gross margin72.3%
Operating margin-5.7%
Net margin-4.5%
FCF margin0.9%
EBITDA margin-3.3%

Returns

ROE-25.8%
ROA-3.7%
ROIC (approx.)—
Asset turnover0.82x

Leverage & solvency

Liabilities / assets83.8%
Debt / equity0.00x
Current ratio3.57x
Interest coverage-3.71x

Cash quality & payout

Operating cash flow / net income-1.44x
Accruals ratio-9.0%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$221.59M$224.17M$199.39M$208.89M$192.88M$186.69M$158.68M$164.32M
Cost of revenue$57.10M$60.97M$58.04M$60.84M$55.76M$53.83M$49.46M$49.26M
Gross profit$164.49M$163.21M$141.35M$148.06M$137.12M$132.86M$109.22M$115.07M
R&D expense$20.60M$19.84M$21.36M$21.05M$21.03M$21.01M$21.52M$19.08M
SG&A expense$125.64M$131.66M$135.88M$122.00M$124.22M$126.38M$119.96M$99.77M
Operating income-$32.55M-$2.54M-$16.18M$2.29M-$8.43M-$18.71M-$32.56M-$4.08M
Interest expense$3.30M$3.29M$3.29M$3.32M$3.28M$3.28M$3.27M$3.32M
Pretax income-$29.85M-$381,000-$13.43M$6.03M-$5.19M-$14.40M-$30.04M-$1.18M
Income tax$0$0$500,000$447,000$24,000-$183,000$665,000$151,000
Net income-$29.85M-$381,000-$13.93M$5.58M-$5.21M-$14.22M-$30.70M-$1.33M
EBITDA-$27.25M$2.66M-$11.19M$7.49M-$3.23M-$13.61M-$27.36M$1.22M
EPS (basic)-0.90-0.01-0.43—-0.16-0.44-0.97—
EPS (diluted)-0.90-0.01-0.43—-0.16-0.44-0.97—
Weighted avg. shares (diluted)33.10M32.90M32.51M—32.17M31.99M31.59M—
Balance sheet
Cash & equivalents$394.72M$246.68M$240.15M$236.01M$255.60M$309.11M$375.28M$427.95M
Short-term investments$166.00M$344.60M$309.47M$347.75M$309.61M$236.44M$145.31M$115.96M
Receivables$81.13M$84.27M$80.86M$75.71M$76.16M$82.15M$80.64M$79.94M
Inventory$23.22M$22.51M$23.80M$21.63M$19.56M$18.40M$14.34M$14.04M
Current assets$730.21M$755.95M$680.56M$702.76M$680.03M$663.92M$636.01M$645.82M
PP&E, net$176.94M$165.31M$156.70M$151.60M$149.32M$139.70M$130.85M$125.09M
Goodwill$862,000$862,000$862,000$862,000$862,000$862,000$862,000$862,000
Total assets$1.09B$1.09B$1.01B$1.02B$995.21M$964.03M$926.10M$931.45M
Current liabilities$204.73M$196.10M$131.75M$151.89M$146.91M$132.21M$111.34M$110.92M
Total liabilities$914.34M$907.44M$845.15M$867.30M$873.32M$860.37M$839.43M$840.54M
Shareholders' equity$177.11M$185.98M$161.21M$152.75M$121.89M$103.66M$86.67M$90.91M
Shares outstanding33.19M32.94M32.85M32.30M32.20M32.10M31.91M31.39M
Cash flow statement
Operating cash flow$4.44M$51.08M-$26.17M$26.21M$34.88M$27.66M-$7.89M$19.23M
Capital expenditure$15.98M$13.56M$6.91M$11.72M$14.83M$10.37M$9.42M$6.84M
Free cash flow-$11.54M$37.52M-$33.08M$14.49M$20.05M$17.29M-$17.31M$12.39M
Investing cash flow$153.20M-$48.64M$30.21M-$48.80M-$89.20M-$100.92M-$38.14M-$122.16M
Financing cash flow$403,000$4.08M$149,000$2.96M$825,000$7.09M$1.73M$2.99M
Depreciation & amortization$5.30M$5.20M$5.00M$5.20M$5.20M$5.10M$5.20M$5.30M
Stock-based compensation$19.49M$20.04M$21.49M$21.11M$21.01M$22.83M$23.34M$16.01M
Share buybacks———$0$0$0$0$0

Free plan shows the latest 8 periods; Pro shows all 47 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.